Access to Medications
Cross Border Internet Pharmacies, one year later
When the federal election was called in 2005, everything was pretty quiet on the Cross Border Internet Pharmacy issue in Canada. Then came the mid term elections in the U.S.
Dollars and sense of access and choice of medications
Recommendations that focus on prescribing older drugs to curb overspending focuses on costs first and the patient last.
National Pharmaceutical Taskforce progress report: Short on policy options
While many of the general principles outlined in the report are seen as positive, the report falls short in identifying specific policy options which will support the delivery of full and equitable access to medications for all Canadians.
Sweeping changes in Ontario may impact all Canadians
People living in provinces outside Central Canada delight in accusing Ontarians of believing that what happens in Ontario affects the entire country – that Ontario is the “center of the universe.” This time, however, it could be true. Profound and innovative changes to the Ontario Drug Benefit Act could be the catalyst for policy changes throughout the country.
Behind closed doors: Canada’s National Pharmaceutical Strategy
Canada's National Pharmaceutical Strategy (NPS) is off to a shaky start. Two years of clandestine meetings have kept the Canadian public in the dark and stakeholders scratching their heads. Who are these people and what are they doing?
“It’s Curtains For You” - Continuing news from the Superbug World
A study from the Queen Elizabeth Hospital in Birmingham has highlighted a hitherto overlooked source of the killer super-bug MRSA
Under Public Scrutiny: A preliminary exploration of the public’s view of the National Pharmace
Pharmaceutical policy is central to the sustainability of not only national pharmacare programs, but the long-term stability of health care systems as a whole. But what do Canadians know and understand about the National Pharmaceutical Strategy and the government's plans.
“Getting Cultured!”- Further Adventures in Living with Superbugs
CAPA members are invited to take a learning journey through the vocabulary and treatment protocols of the Superbug world.
The patient perspective in health policy: Are we there yet?
This year has seen more meaningful patient involvement in Health Canada policy issues than ever before. We were involved as equal partners on the Expert Advisory Panel on Cox-2, in developing guidelines for a National Pharmaceutical Strategy, and consulted on cross border Internet pharmacy. It feels good. But don’t be fooled.
